Obesity: A Disease

In this episode Co-Authors, Dr. Harold Bays and Dr. Angela Fitch, review the article Obesity, thrombosis, venous disease, lymphatic disease and lipedema: An Obesity Medicine Association Clinical Practice Statement 2023.

In this Episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings interviews, Dr. Michelle Look, a highlighted speaker from the Obesity Medicine 2023 Conference, Early Intervention in Weight Management: Treating Pre-Obesity. Topics covered will include identifying the risks associated with pre-obesity, best practices for screening and taking a weight history, and reviewing practical treatment strategies to halt the progression of the disease. Episode Guests Michelle Look, MD, FAAFP Related Resources https://academy.obesitymedicine.org/content/overcoming-obesity-2023-early-intervention-weight-management-treating-pre-obesity-recorded#group-tabs-node-course-default1 

In this episode, Dr. Harold Bays and Dr. Carolynn Francavilla discuss their experience with prior authorizations for obesity medications including the highly effective GLP-1 medications. 

In this Episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings interviews, Dr. Marie-Pierre St Onge, a highlighted speaker from the Obesity Medicine 2023 Conference, Do Sleepy Brains Make Poor Food & Other Lifestyle Choices? Topics covered include the connection between sleep status and obesity, sleep deprivation and it's impacts on energy balance and physical activity and the benefits of improving sleep habits. Episode Guests Marie-Pierre St-Onge, PhD Related Resources https://academy.obesitymedicine.org/content/oma-2023-spring-summit-do-sleepy-brains-make-poor-food-other-lifestyle-choices-impact-sleep Related Resources Obesity Algorithm©

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts. To access other resources from the clinical leader in Obesity Medicine, please visit: www.obesitymedicine.org. In this three part series, Dr. Bays and Dr. Bindlish review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Episode Guests Dr. Shagun Bindlish, MD Dr. Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Related Resources Obesity Pillars®

In this episode, we will be hearing from Dr. Suzanne Cuda, President and Medical Director for Alamo City Healthy Kids and Families. Joining her is Nancy Browne and Dr. Valarie O’Hara. Nancy is a nurse practitioner, pediatric obesity medicine specialist and is also a co-author of the OMA Pediatric Obesity Clinical Practice Statements. Dr. O’Hara is an ABOM certified obesity specialist and the medical director of the WOW 4 Wellness Clinic. Today’s topics are foundational therapies, shared decision making, off-label treatment and pharmacotherapy treatment options in pediatrics. Episode Guests Dr. Suzanne Cuda Nancy Browne Dr. Valarie O’Hara Related Resources Pediatric Obesity Algorithm® OMA Pediatric Resources Webpage OMA Blog

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts. To access other resources from the clinical leader in Obesity Medicine, please visit: www.obesitymedicine.org. In this three part series, Dr. Bays and Dr. Bindlish review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Episode Guests Dr. Shagun Bindlish, MD Dr. Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Related Resources Obesity Pillars®

In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings and Dr. Robert Lustig, discuss non-alcoholic fatty liver disease and obesity. Dr. Lustig is a professor of pediatric in the division of endocrinology at UCSF. In addition to his rich contribution to the medical literature, he is an author of several best-selling books, and a passionate advocate for promoting metabolic health and nutrition especially with respect to the health risks of sugar. He was the keynote speaker at the OMA’s 2022 Fall Obesity Summit. His presentation was titled ” The BIG Picture: NAFLD, the sentinel disease of metabolic syndrome”. Topics discussed include the health consequences of sugar consumption, the prevalence of NAFLD, diagnosing NAFLD, and treatment through medication, nutrition, and weight loss. Episode Guests Dr. Nick Pennings, DO, FOMA Dr. Robert Lustig, MD Resources Mentioned Fat Chance and Metabolical, by Dr. Lustig Related Resources Overcoming Obesity Conference Obesity Algorithm® Obesity Medicine Association Blog

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts. In this three part series, Dr. Bays and Dr. Lowe-Clayton review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Episode Guests Tiffany Lowe-Clayton, DO Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Related Resources Obesity Pillars Journal

In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings and Dr. Andreas Acosta discuss the importance of aligning appropriate lifestyle interventions to each of the four key phenotypes that explain about eighty-five percent of patients with obesity. Andreas Acosta, MD, PhD is an assistant professor in the Division of Gastroenterology and Hepatology at the Mayo Clinic in Rochester, MN. Dr. Acosta presented his exciting research at the OMA Fall 2022 Obesity Summit in Anaheim, CA, in a presentation titled “Phenotype-Guided Lifestyle Intervention for Obesity Management" Topics discussed include hungry gut, emotional eater, and slow metabolizer phenotypes. Additional topics include overlapping phenotypes, phenotype profiling, and treatment approaches. Episode Guests Andreas Acosta, MD, PhD Nicholas Pennings, DO, FOMA, FACOFP